Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 193

1.

Characteristics of rapid vs slow progression to type 1 diabetes in multiple islet autoantibody-positive children.

Achenbach P, Hummel M, Thümer L, Boerschmann H, Höfelmann D, Ziegler AG.

Diabetologia. 2013 Jul;56(7):1615-22. doi: 10.1007/s00125-013-2896-y. Epub 2013 Mar 29.

PMID:
23539116
2.

A strategy to find gene combinations that identify children who progress rapidly to type 1 diabetes after islet autoantibody seroconversion.

Bonifacio E, Krumsiek J, Winkler C, Theis FJ, Ziegler AG.

Acta Diabetol. 2014;51(3):403-11. doi: 10.1007/s00592-013-0526-2. Epub 2013 Nov 19.

PMID:
24249616
3.

Non-HLA gene effects on the disease process of type 1 diabetes: From HLA susceptibility to overt disease.

Lempainen J, Laine AP, Hammais A, Toppari J, Simell O, Veijola R, Knip M, Ilonen J.

J Autoimmun. 2015 Jul;61:45-53. doi: 10.1016/j.jaut.2015.05.005. Epub 2015 Jun 12.

PMID:
26074154
4.

Triple specificity of ZnT8 autoantibodies in relation to HLA and other islet autoantibodies in childhood and adolescent type 1 diabetes.

Andersson C, Vaziri-Sani F, Delli A, Lindblad B, Carlsson A, Forsander G, Ludvigsson J, Marcus C, Samuelsson U, Ivarsson S, Lernmark A, Larsson HE; BDD Study Group..

Pediatr Diabetes. 2013 Mar;14(2):97-105. doi: 10.1111/j.1399-5448.2012.00916.x. Epub 2012 Sep 10.

PMID:
22957668
5.

Screening for insulinoma antigen 2 and zinc transporter 8 autoantibodies: a cost-effective and age-independent strategy to identify rapid progressors to clinical onset among relatives of type 1 diabetic patients.

Gorus FK, Balti EV, Vermeulen I, Demeester S, Van Dalem A, Costa O, Dorchy H, Tenoutasse S, Mouraux T, De Block C, Gillard P, Decochez K, Wenzlau JM, Hutton JC, Pipeleers DG, Weets I; Belgian Diabetes Registry..

Clin Exp Immunol. 2013 Jan;171(1):82-90. doi: 10.1111/j.1365-2249.2012.04675.x.

6.

Impact of diabetes susceptibility loci on progression from pre-diabetes to diabetes in at-risk individuals of the diabetes prevention trial-type 1 (DPT-1).

Butty V, Campbell C, Mathis D, Benoist C; DPT-1 Study Group..

Diabetes. 2008 Sep;57(9):2348-59. doi: 10.2337/db07-1736. Epub 2008 Jun 12.

7.

An interferon-induced helicase (IFIH1) gene polymorphism associates with different rates of progression from autoimmunity to type 1 diabetes.

Winkler C, Lauber C, Adler K, Grallert H, Illig T, Ziegler AG, Bonifacio E.

Diabetes. 2011 Feb;60(2):685-90. doi: 10.2337/db10-1269.

8.

Islet autoantibodies are associated with HLA-DQ genotypes in Han Chinese patients with type 1 diabetes and their relatives.

Wang JP, Zhou ZG, Lin J, Huang G, Zhang C, Yang L, Yuan Y, Zhou HF, Zhou M, Hou C, Zhou WD, Peng H, Hagopian WA.

Tissue Antigens. 2007 Nov;70(5):369-75.

PMID:
17919266
9.

Disease-associated autoantibodies and HLA-DQB1 genotypes in children with newly diagnosed insulin-dependent diabetes mellitus (IDDM). The Childhood Diabetes in Finland Study Group.

Sabbah E, Savola K, Kulmala P, Reijonen H, Veijola R, Vähäsalo P, Karjalainen J, Ilonen J, Akerblom HK, Knip M.

Clin Exp Immunol. 1999 Apr;116(1):78-83.

10.

Do non-HLA genes influence development of persistent islet autoimmunity and type 1 diabetes in children with high-risk HLA-DR,DQ genotypes?

Steck AK, Zhang W, Bugawan TL, Barriga KJ, Blair A, Erlich HA, Eisenbarth GS, Norris JM, Rewers MJ.

Diabetes. 2009 Apr;58(4):1028-33. doi: 10.2337/db08-1179. Epub 2009 Feb 2.

11.

Autoantibodies and high-risk HLA susceptibility markers in first-degree relatives of Brazilian patients with type 1 diabetes mellitus: a progression to disease based study.

Alves LI, Davini E, Correia MR, Fukui RT, Santos RF, Cunha MR, Rocha DM, Volpini WM, Silva ME.

J Clin Immunol. 2012 Aug;32(4):778-85. doi: 10.1007/s10875-012-9673-4. Epub 2012 Mar 9.

PMID:
22402866
12.

Non-HLA type 1 diabetes genes modulate disease risk together with HLA-DQ and islet autoantibodies.

Maziarz M, Hagopian W, Palmer JP, Sanjeevi CB, Kockum I, Breslow N, Lernmark Å; Swedish Childhood Diabetes Register.; Diabetes Incidence in Sweden Study Group.; Type 1 Diabetes Genetics Consortium..

Genes Immun. 2015 Dec;16(8):541-51. doi: 10.1038/gene.2015.43. Epub 2015 Oct 29.

13.

A strategy for combining minor genetic susceptibility genes to improve prediction of disease in type 1 diabetes.

Winkler C, Krumsiek J, Lempainen J, Achenbach P, Grallert H, Giannopoulou E, Bunk M, Theis FJ, Bonifacio E, Ziegler AG.

Genes Immun. 2012 Oct;13(7):549-55. doi: 10.1038/gene.2012.36. Epub 2012 Aug 30.

PMID:
22932816
14.

Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children.

Ziegler AG, Rewers M, Simell O, Simell T, Lempainen J, Steck A, Winkler C, Ilonen J, Veijola R, Knip M, Bonifacio E, Eisenbarth GS.

JAMA. 2013 Jun 19;309(23):2473-9. doi: 10.1001/jama.2013.6285.

15.

Predictive power of screening for antibodies against insulinoma-associated protein 2 beta (IA-2beta) and zinc transporter-8 to select first-degree relatives of type 1 diabetic patients with risk of rapid progression to clinical onset of the disease: implications for prevention trials.

De Grijse J, Asanghanwa M, Nouthe B, Albrecher N, Goubert P, Vermeulen I, Van Der Meeren S, Decochez K, Weets I, Keymeulen B, Lampasona V, Wenzlau J, Hutton JC, Pipeleers D, Gorus FK; Belgian Diabetes Registry..

Diabetologia. 2010 Mar;53(3):517-24. doi: 10.1007/s00125-009-1618-y. Epub 2009 Nov 29.

PMID:
20091020
16.

Characterisation of rapid progressors to type 1 diabetes among children with HLA-conferred disease susceptibility.

Pöllänen PM, Lempainen J, Laine AP, Toppari J, Veijola R, Vähäsalo P, Ilonen J, Siljander H, Knip M.

Diabetologia. 2017 Mar 31. doi: 10.1007/s00125-017-4258-7. [Epub ahead of print]

PMID:
28364254
17.

Lymphoid tyrosine phosphatase (LYP/PTPN22) Arg620Trp variant regulates insulin autoimmunity and progression to type 1 diabetes.

Hermann R, Lipponen K, Kiviniemi M, Kakko T, Veijola R, Simell O, Knip M, Ilonen J.

Diabetologia. 2006 Jun;49(6):1198-208. Epub 2006 Apr 14.

PMID:
16614815
18.

The three ZNT8 autoantibody variants together improve the diagnostic sensitivity of childhood and adolescent type 1 diabetes.

Andersson C, Larsson K, Vaziri-Sani F, Lynch K, Carlsson A, Cedervall E, Jönsson B, Neiderud J, Månsson M, Nilsson A, Lernmark A, Elding Larsson H, Ivarsson SA.

Autoimmunity. 2011 Aug;44(5):394-405. doi: 10.3109/08916934.2010.540604. Epub 2011 Jan 19.

PMID:
21244337
19.

Shared and distinct genetic variants in type 1 diabetes and celiac disease.

Smyth DJ, Plagnol V, Walker NM, Cooper JD, Downes K, Yang JH, Howson JM, Stevens H, McManus R, Wijmenga C, Heap GA, Dubois PC, Clayton DG, Hunt KA, van Heel DA, Todd JA.

N Engl J Med. 2008 Dec 25;359(26):2767-77. doi: 10.1056/NEJMoa0807917. Epub 2008 Dec 10.

20.

Association analysis of PTPN22, CTLA4 and IFIH1 genes with type 1 diabetes in Colombian families.

Rodríguez A, Alfaro JM, Balthazar V, Pineda Trujillo N.

J Diabetes. 2015 May;7(3):402-10. doi: 10.1111/1753-0407.12192. Epub 2014 Sep 10.

PMID:
25042601

Supplemental Content

Support Center